Viewing offline content

Limited functionality available

Dismiss
Deloitte UK
  • Services

    Highlights

    • Major Programmes

      Connecting people and technology to anticipate and respond to ever-changing conditions, and solve for society’s greatest challenges.

    • Deloitte Ventures

      Connecting our clients to emerging start-ups, leading technology players and a whole raft of new Deloitte talent.

    • Towards net zero together

      Discover the people leading the change and what could be possible for your business.

    • Audit & Assurance

      • Audit
      • Audit - IASPlus
      • Assurance
    • Consulting

      • Core Business Operations
      • Customer and Marketing
      • Enterprise Technology & Performance
      • Human Capital
      • Strategy, Analytics and M&A
    • Financial Advisory

      • Mergers & Acquisitions
      • Performance Improvement
    • Legal

      • Legal Advisory
      • Legal Managed Services
      • Legal Management Consulting
    • Deloitte Private

      • Family Enterprises
      • Private Equity
      • Emerging Growth
    • Risk Advisory

      • Accounting and Internal Controls
      • Cyber and Strategic Risk
      • Regulatory and Legal
    • Tax

      • Global Business Tax Services
      • Indirect Tax
      • Global Employer Services
  • Industries

    Highlights

    • Ecosystems & Alliances

      An engine to embrace and harness disruptive change

    • Resilience Reimagined

      Resilient organisations thrive before, during and after adversity. How will you become more resilient?

    • Consumer

      • Automotive
      • Consumer Products
      • Retail, Wholesale & Distribution
      • Transportation, Hospitality & Services
    • Energy, Resources & Industrials

      • Industrial Products & Construction
      • Mining & Metals
      • Energy & Chemicals
      • Power, Utilities & Renewables
      • Future of Energy
    • Financial Services

      • Banking
      • Capital Markets
      • Insurance
      • Investment Management
      • Real Estate
      • FinTech & Alternative Finance
    • Government & Public Services

      • Health & Human Services
      • Defence, Security & Justice
      • Central Government
      • Infrastructure, Transport and Regional Government
    • Life Sciences & Health Care

      • Health Care
      • Life Sciences
    • Technology, Media & Telecommunications

      • Telecommunications, Media & Entertainment
      • Technology
  • Insights

    Deloitte Insights

    Highlights

    • Deloitte Insights Magazine

      Explore the latest issue now

    • Deloitte Insights app

      Go straight to smart with daily updates on your mobile device

    • Weekly economic update

      See what's happening this week and the impact on your business

    • Strategy

      • Business Strategy & Growth
      • Digital Transformation
      • Governance & Board
      • Innovation
      • Marketing & Sales
      • Private Enterprise
    • Economy & Society

      • Economy
      • Environmental, Social, & Governance
      • Health Equity
      • Trust
      • Mobility
    • Organization

      • Operations
      • Finance & Tax
      • Risk & Regulation
      • Supply Chain
      • Smart Manufacturing
    • People

      • Leadership
      • Talent & Work
      • Diversity, Equity, & Inclusion
    • Technology

      • Data & Analytics
      • Emerging Technologies
      • Technology Management
    • Industries

      • Consumer
      • Energy, Resources, & Industrials
      • Financial Services
      • Government & Public Services
      • Life Sciences & Health Care
      • Technology, Media, & Telecommunications
    • Spotlight

      • Deloitte Insights Magazine
      • Press Room Podcasts
      • Weekly Economic Update
      • COVID-19
      • Resilience
      • Top 10 reading guide
  • Careers

    Highlights

    • Hear from our people

      At Deloitte, our people are at the heart of what we do. Discover their stories to find out more about Life at Deloitte.

    • Careers Home

  • UK-EN Location: United Kingdom-English  
  • UK-EN Location: United Kingdom-English  
    • Dashboard
    • Saved Items
    • Content feed
    • Profile/Interests
    • Account settings

Welcome back

Still not a member? Join My Deloitte

The role of health services innovators in the future of health

by Steve Margolis, Peter Micca, Maulesh Shukla, Jessica Overman
  • Save for later
  • Download
  • Share
    • Share on Facebook
    • Share on Twitter
    • Share on Linkedin
    • Share by email
Deloitte Insights
  • Strategy
    Strategy
    Strategy
    • Business Strategy & Growth
    • Digital Transformation
    • Governance & Board
    • Innovation
    • Marketing & Sales
    • Private Enterprise
  • Economy & Society
    Economy & Society
    Economy & Society
    • Economy
    • Environmental, Social, & Governance
    • Health Equity
    • Trust
    • Mobility
  • Organization
    Organization
    Organization
    • Operations
    • Finance & Tax
    • Risk & Regulation
    • Supply Chain
    • Smart Manufacturing
  • People
    People
    People
    • Leadership
    • Talent & Work
    • Diversity, Equity, & Inclusion
  • Technology
    Technology
    Technology
    • Data & Analytics
    • Emerging Technologies
    • Technology Management
  • Industries
    Industries
    Industries
    • Consumer
    • Energy, Resources, & Industrials
    • Financial Services
    • Government & Public Services
    • Life Sciences & Health Care
    • Tech, Media, & Telecom
  • Spotlight
    Spotlight
    Spotlight
    • Deloitte Insights Magazine
    • Press Room Podcasts
    • Weekly Economic Update
    • COVID-19
    • Resilience
    • Top 10 reading guide
    • UK-EN Location: United Kingdom-English  
      • Dashboard
      • Saved Items
      • Content feed
      • Profile/Interests
      • Account settings
    11 minute read 06 August 2020

    The role of health services innovators in the future of health Driving transformation toward a consumer-centric, data-reliant, technology-forward vision

    11 minute read 06 August 2020
    • Steve Margolis United States
    • Peter Micca United States
    • Maulesh Shukla India
    • Jessica Overman United States
    • Jessica Overman United States
    • Save for later
    • Download
    • Share
      • Share on Facebook
      • Share on Twitter
      • Share on Linkedin
      • Share by email
    • Executive summary
    • Introduction
    • Research findings
    • Shifting the industry toward the future together

    The COVID-19 pandemic provides an opportunity to transform toward the future of health: a future driven by consumer-centricity, data reliance, and new technologies. Learn about the ways health care incumbents can work with health services innovators and their nontraditional expertise and solutions.

    Executive summary

    Who will drive the health care industry’s transformation toward a future vision of being consumer-centric, efficient, high-quality, data- and technology-driven, and highly accessible? While some of the industry incumbents—health systems and health plans—will spur some change, Deloitte’s vision1 of the future of health expects nontraditional entrants into the industry to bring relevant expertise and solutions for the industry’s legacy ills. The entry of major retail and consumer technology companies into the health care industry, improving and disrupting it, is well documented.2 However, another set of new entrants is also busy transforming the industry in partnership with incumbents and gaining traction in the industry. We call them health services innovators.

    What are health services innovators?

    Health services innovators are companies that offer innovative solutions and services to several industry incumbents—health systems and health plans—as well as consumers. They are nimble, digital tech-enabled, and consumer-focused companies that aim to provide new solutions and services to help incumbents solve some of health care’s most important problems.

    Learn more

    Explore the Health care collection

    Visit the Health Forward blog

    Learn about Deloitte's services

    Go straight to smart. Get the Deloitte Insights app

    To understand these innovators’ perspectives on the future of health, we interviewed CEOs, founders, and other visionary leaders (chief executives) of several health services innovators. We conducted these interviews during the peak of the COVID-19 pandemic to understand both the impact of the pandemic and how these companies expect to transform health care.

    In a previous set of interviews with 35 CEOs from health systems and health plans,3 we found out that the industry is shifting toward alternative care settings, stronger consumer engagement, and better use of data and technologies. These shifts can be opportunities for health services innovators who aim to partner with incumbents. Indeed, our innovator company interviewees agree with many elements of our Future of Health vision.4

    Health services innovator chief executives told us they are:

    • Playing a critical role in a broad-based transformation of health care. They are positioning themselves to fill the gaps created and overlooked (for various reasons) by many health care incumbents.
    • Building capabilities and business models that will allow incumbents to transform the industry. The health service innovator chief executives are strengthening their companies' position in the future by building business models in partnership with incumbents around well-being and care delivery (e.g., digital medicine, sensors for appropriate care), data and platforms (e.g., AI-based predictive analytics platforms), and care enablement (e.g., personalized financing tools, access tools).

    The health services innovator chief executives also said that the COVID-19 pandemic will act as an accelerator of change for the industry, and they are already seeing it happen. They said it exposed several broken aspects of the legacy health care system, mainly incoherent technology initiatives and a traditional mindset. They expect the pandemic to accelerate transparency and data interoperability, access and affordability, automation, and analytics.

    In contrast, health care incumbent CEOs, who we interviewed in late 2019 (prior to the COVID-19 pandemic), had mixed views on threats from new entrants—both tech and retail giants and health services innovators. Some were worried about them as potential competitors, others dismissed them. However, the aftermath of COVID-19 brings an opportunity for them to play to each other’s strengths. The health services innovators told us that that they see their opportunity as collaborating and improving, not competing with incumbents and disrupting the industry. Incumbents, with their industry expertise, capital, and regulatory expertise, and innovators, with their tech-enabled, data-native, analytics-driven, and consumer-centric approach, together can push the industry toward the future of health.

    Introduction

    Given the pandemic’s exposure of the many challenges with the current health care system, many inside and outside the industry agree that transformation is needed5 and seek a future driven by consumerism, data availability and use, and digital and scientific innovation.6 This vision requires significant business model transformation by many incumbents—health care providers, health plans, and life sciences organizations—as well as new entrants spurring change in the industry.

    Many health care observers think the term “new entrants” consists primarily of large retail and consumer technology organizations entering the health care industry. Some have reported on the market activities and strategies of these large retailer and consumer technology companies with a mix of capital, capabilities, and purpose.7 However, another group of organizations is bringing about innovation in health services through new approaches, solutions, and technologies. We call them health services innovators. These new entrants have distinct characteristics that differentiate them from the industry incumbents and the large new entrants—they are nimble, tech-enabled, consumer-focused, and led by industry experts (figure 1).

    Health services innovators?

    We interviewed chief executives of several health services innovators at the height of the COVID-19 pandemic from February–April 2020 to understand their perspective on where the industry is heading, how the pandemic could affect industry transformation, and to learn more about how they see their role in achieving that future.

    Research findings

    In the next 10 years, health care is expected to be more consumer-centric, affordable, and tech-driven

    Like the incumbent CEOs we spoke with late in 2019, chief executives of the health services innovators say that the three biggest changes to the industry in the next 10 years will center around:

    • Consumer-centricity
    • Evolution of value-based care and affordability
    • Pervasive use of advanced technologies and analytics

    Consumer-centricity: As consumers become more involved in their health care choices, it is imperative for the industry to become more consumer-centric. It begins with data access and transparency at each stage of decision-making. Historically, consumers have had to deal with a lack of transparency in health care—both about health care costs and the value of services in improving their health. Without that information, they have had a hard time making informed decisions. The result, according to the chief executives of health services innovators, is a waste of time and money, and more importantly, poor health and well-being outcomes.

    “One of the biggest problems today is the lack of transparency and the inability for the average consumer to make informed decisions about their health care, particularly when it comes to what physician resources to avail themselves of—who to see, where to go, when to go is a complete mystery.”

    —Chief executive, health services innovator

    However, with the proliferation of data and more exposure to out-of-pocket spending, consumers are demanding more transparency and are gaining ground in their ability to make decisions about their health. For instance, over 40% of consumers today use personal technologies to measure fitness, compared to just 17% in 2013, and one in every two consumers would likely change their physician if they are dissatisfied with the communication aspect of the relationship, according to the Deloitte 2020 survey of US health care consumers.8 Chief executives of health services innovators believe several health care companies, including themselves, are making rapid strides in focusing more on consumers. In the next 10 years, they say consumers will have access to more accurate information which can promote informed decision-making and lead to better health outcomes.

    Evolution of value-based care and affordability: Value can come from improving quality or reducing costs or both. However, according to the chief executives of health services innovators, current value-based care arrangements have focused primarily on cost reduction as a measure of success, not quality of care and outcomes. As value-based care models mature, all stakeholders, including plans, providers, employers, and even consumers will likely demand higher quality as well as affordability. Chief executives of health care service innovators say that in the next few years, payment models will become more outcome-centered, and they expect to see increased transparency and availability of data about physician and health system performance to validate outcomes.

    “Health care innovation has to start to focus less on absolute therapeutic capability and more on how we deliver care and products and services that we know work to more and more people at a much lower price point, so it is much more accessible, and much better from a value equation perspective.”

    —Chief executive, health services innovator

    Pervasive use of advanced technologies and analytics: The health care system largely continues to focus on a 20th century model centered around an infrastructure of buildings, people, assets, and products. However, the chief executives of health services innovators believe mindsets are changing to a 21st century model that envisions data, platforms, interoperability, digital and virtual solutions, and data science insights as the new infrastructure. Increased use of technologies and analytics can help enable the shift to accessible, affordable, quality health care in the next 20 years, according to the chief executives of health services innovators.

    “Automating certain areas where today they are going to be forced to automate certain workflows purely based upon solvency and surviving: That is going to last long into the future, in terms of saying why did we ever have a person doing this in the first place.”

    —Chief executive, health services innovator

    The COVID-19 pandemic is accelerating the industry’s transformation

    The chief executives of health services innovators agree that the COVID-19 crisis will have a lasting impact on how the industry functions. They say the pandemic will speed up the industry’s transformation in two major ways:

    Fixing today’s broken system: The pandemic has shown how many processes and experiences in health care are outdated. For instance, the lack of access to accurate data from multiple sources hindered care delivery, triage, and patient transfers. Additionally, amid the pandemic, several hospital leaders were still using outdated technologies such as faxes to communicate with physicians and other hospitals. It has revealed several opportunities to fix broken aspects of the industry, particularly in areas such as care delivery, collaboration, and affordability. The chief executives of health services innovators say that many health care leaders now understand the implications of these broken aspects and are ready to fix them.

    “COVID-19 is what’s needed to show people how inefficient our workflows are.”

    —Chief executive, health services innovator

    Broad-based adoption of data and technology: The chief executives of health service innovators also agree the pandemic will accelerate widespread adoption of data and analytics and advanced digital technologies. For instance, adoption of virtual health tools, which otherwise might have taken years to reach today’s levels, accelerated rapidly. Technologies such as digital assistants will likely become common in patient-facing and internal processes. More data, interoperability, and analytics can also help in utilization management, population health surveillance, and real-time data-sharing and communication with other organizations.

    “[Health organizations will look to] automate certain areas and workflows purely based upon surviving.”

    —Chief executive, health services innovator

    Health services innovators are partnering with incuments to deliver transformative solutions around care delivery, data and platform, and care enablement

    Innovators are partnering with incumbents to deliver transformative solutions

    Greater data and interoperability, increased access to care, and empowered consumers will likely be the main features of the future of health. Health services innovators are building capabilities and business models around:

    Well-being and care delivery: The innovators are working on solutions that enable sustained well-being for consumers and allow incumbents to explore innovative ways to deliver care. For instance, they are developing sensors, wearables, and digital apps that help generate novel insights into patient health issues, help ensure medication adherence, and enable physicians to make informed care-delivery decisions.

    “If a physician is talking to a patient over the phone about medication, he would like to know how they are using them and how their body is responding. We can answer that in a scientific, data-driven way through our solutions.”

    —Chief executive, health services innovator

    Data and platforms: The innovators are partnering with incumbents to gather and assimilate data, clean it, and create data platforms and infrastructure that can help incumbents as well as consumers make quicker care decisions at a lower cost. For instance, they are creating platforms that make it easier for consumers to select physicians, including specialists. Innovators are also building AI platforms that use predictive analytics to improve quality and health outcomes. Their partnerships include those with health systems, health plans as well as pharmacies, value-based care conveners, and other community providers.

    Care enablement: The innovators are also building solutions that help increase access and convenience. For instance, they are developing flexible financing tools and partnering with health systems to deliver financing options to consumers and employers. In cases where some consumers are finding it difficult to pay their personal health care bills due to the COVID-19 crisis,9 innovators are partnering with health systems and insurance companies to offer consumers lower interest rates, partnerships with credit card companies, and longer repayment time for their out-of-pocket expenses. These solutions aim to increase access to care by reducing financial barriers and health care navigation hurdles. The innovators are also easing physicians’ jobs by automating some time-consuming, mundane but important tasks such as adding diagnoses codes in documentation, ordering medication, and populating billing templates.

    “Access is going to get transformed, because everyone everywhere has a mobile phone. We will be able to do vastly more to support most people with a health problem using just a mobile device.”

    —Chief executive, health services innovator

    Partnerships with incumbents are key to broad-based transformation.

    Health services innovator chief executives told us they are focusing on transforming the industry not through disruption but are instead partnering with incumbents by improving areas where they feel incumbents have been slow to respond, including technology, data and information, and consumers.

    The health care incumbent CEOs in our earlier research said they are focused on investing in care management, digital tools, and consumer engagement technologies to better position themselves for the future. The chief executives of health service innovators said they are aligning their solutions to meet these burgeoning demands from incumbents.

    “Through our solutions, if we can get more collaboration between the health plans, the employers, and the health systems, ultimately putting the consumers first, that is a real opportunity for us.”

    —Chief executive, health services innovator

    Shifting the industry toward the future together

    In our previous research, we asked the CEOs of health care incumbents for their views on several new entrants—both large tech and retail giants, and the health services innovators—entering the industry. They had mixed thoughts. Some were worried about competition, others dismissed them. However, incumbents may be overlooking the role of health services innovators as partners in helping them transform and improve the industry. There was a consensus among the chief executives of the health services innovators that they want to collaborate and improve, not compete and disrupt, the industry.

    The aftermath of COVID-19 may bring an opportunity for them to play to each other’s strengths. While they have been working together for many years, they envision more enduring opportunities for partnership and collaboration. Incumbents, with their industry experience, capital, and regulatory expertise, and Innovators with their tech-enabled, data-driven, and consumer-centric approach, can together push the industry toward the future of health.

    Acknowledgments

    Project team: Wendy Gerhardt provided oversight to the project, interviewed many of the chief executives of health services innovators, as well as helped interpret the interview findings and edit the paper. Julie Solar and Gaurav Mehta helped in planning, question development, interpreting the interview findings, and editing of the paper.

    The authors would like to thank Ollie McCoy, Steve Burrill, David Betts, Ralph Judah, Lindsay Peeler, Sarah Thomas, Ramani Moses, Laura DeSimio, and the many others who contributed to the success of this project.

    This study would not have been possible without our research participants who graciously agreed to participate in the interviews. They were generous with their time and insights.

    Cover image by: Traci Daberko

    Endnotes
      1. Deloitte, “The future of health,” accessed June 30, 2020. View in article

      2. Angela Chen, “As tech companies move into health care, here’s what to watch in 2019,” Verge, January 3, 2019; Nancy Huynh, “How the 'Big 4' tech companies are leading healthcare innovation,” Heathcare Weekly, February 27, 2019. View in article

      3. Michael Main, Michael Schwartz, and Wendy Gerhardt, Findings from the Deloitte 2019 Health Care CEO Perspectives Study, Deloitte Insights, January 17, 2020. View in article

      4. Deloitte, “The future of health,” accessed June 30, 2020. View in article

      5. Julia L. Marcus and Joshua Barocas, “The coronavirus pandemic could transform our health care system—for the better,” STAT, April 14, 2020. View in article

      6. Vipul Jain, “How technology will transform healthcare after the coronavirus pandemic,” YourStory, April 28, 2020. View in article

      7. Christina Farr, “Amazon's vision for the future of the health care is becoming clear,” CNBC, December 18, 2018; CB Insights, “How Google plans to use AI to reinvent the $3 trillion US healthcare industry,” accessed June 29, 2020; Julie Spitzer, “7 notes on Apple's health strategy so far,” Becker's Hospital Review, January 16, 2019; Joyce Famakinwa, “Primary care plans put Walmart back in the health care spotlight,” Home Health Care News, September 3, 2019. View in article

      8. Deloitte 2020 survey of US health care consumers. View in article

      9. Megan Leonhardt, “54% of Americans worry about expenses tied to coronavirus—here's how to cut medical costs if you get sick,” CNBC, March 13, 2020. View in article

    Show moreShow less

    Topics in this article

    Health Care , Health Information Technology , Life Sciences & Health Care , Health Equity

    Deloitte Health Care

    Innovation starts with insight and seeing challenges in a new way. Amid unprecedented uncertainty and change across the health care industry, stakeholders are looking for new ways to transform the journey of care. Our US Health Care practice helps clients transform uncertainty into possibility and rapid change into lasting progress. Comprehensive audit, advisory, consulting, and tax capabilities can deliver value at every step, from insight to strategy to action. Our people know how to anticipate, collaborate, innovate, and create opportunity from even the unforeseen obstacle.

    Learn more
    Get in touch
    • Steve Margolis
    • Managing director
    • Deloitte Consulting LLP
    • smargolis@deloitte.com
    • +1 571 512 0672
    Download Subscribe

    Related content

    img Trending

    How the virtual health landscape is shifting in a rapidly changing world

    Article 2 years ago
    img Trending

    Is the hospital of the future here today?

    Article 2 years ago
    img Trending

    Rethinking the physician of the future: Embracing new technologies, empathy, and new models of care

    Article 2 years ago
    img Trending

    Clinical leaders' top concerns about re-opening

    Article 2 years ago

    Explore more on Health care

    • The future of virtual health Article2 years ago
    • The future of work in health and human services Article2 years ago
    • Medicaid in 2040 Article2 years ago
    • Health tech investment trends: How are investors positioning for the future of health? Article2 years ago
    • The economic impact of COVID-19 (novel coronavirus) Article2 years ago
    • Hospital revenue trends Article2 years ago
    Steve Margolis

    Steve Margolis

    Steve Margolis, Deloitte Consulting LLP, is a managing director in the Health Care practice where he specializes in strategic, operational, and technology transformations for both health plans and integrated delivery systems including ACOs. Margolis is a former health plan executive and has over 20 years of executive level experience at both national for-profit and regional not-for-profit health plans where he was responsible for the divisional profit and loss for commercial group, government programs, and ancillary services.

    • smargolis@deloitte.com
    Peter Micca

    Peter Micca

    Partner | Life Sciences & Health Care

    Peter Micca, Deloitte & Touche LLP, is a partner with 30 years of experience serving a broad array of clients in all sectors of the health care, technology, and life sciences industries. He has significant experience with health technology organizations, software as a service (SaaS) organizations, pharmacy benefit management, clinical and diagnostic operations, emerging growth, as well as private equity–financed organizations in life sciences and health technology and services. Micca applies a deep knowledge of industry sector business issues regarding the emerging trends surrounding consumerism, convergence, cost considerations, regulatory and compliance issues, and consolidation.

    • pmicca@deloitte.com
    • +1 212 436 5468
    Maulesh Shukla

    Maulesh Shukla

    Executive Manager | Deloitte Center for Health Solutions| Deloitte Services LP

    Maulesh Shukla, Deloitte Services LP, is an executive manager with the Deloitte Center for Health Solutions. For the past fifteen years, his research has covered a wide range of topics in the realm of health plans, as well as hospital and health systems. His recent research has focused on the future of health, health equity, and health care financial transformation. He holds an MBA from IBS, Hyderabad, India.

    • mshukla@deloitte.com
    • +1 678 299 7331
    Jessica Overman

    Jessica Overman

    Lead research analyst

    Jessica Overman, MPH, is a lead research analyst with the Deloitte Center for Health Solutions, Deloitte Services LP. Through her research, she helps inform Deloitte’s health care and life sciences clients about emerging trends, challenges, and opportunities for driving health equity. Her most recent research focuses on consumer sentiments on COVID-19 vaccinations, addressing the use of race in care delivery, and exploring strategies the biopharma industry is pursuing to enhance clinical trial diversity. She holds a BS in public health, and MPH in practice and policy from the University of Maryland. She is based out of the Rosslyn office in Arlington, VA.

    • joverman@deloitte.com

    Share article highlights

    See something interesting? Simply select text and choose how to share it:

    Email a customized link that shows your highlighted text.
    Copy a customized link that shows your highlighted text.
    Copy your highlighted text.

    The role of health services innovators in the future of health has been saved

    The role of health services innovators in the future of health has been removed

    An Article Titled The role of health services innovators in the future of health already exists in Saved items

    Invalid special characters found 
    Forgot password

    To stay logged in, change your functional cookie settings.

    OR

    Social login not available on Microsoft Edge browser at this time.

    Connect Accounts

    Connect your social accounts

    This is the first time you have logged in with a social network.

    You have previously logged in with a different account. To link your accounts, please re-authenticate.

    Log in with an existing social network:

    To connect with your existing account, please enter your password:

    OR

    Log in with an existing site account:

    To connect with your existing account, please enter your password:

    Forgot password

    Subscribe

    to receive more business insights, analysis, and perspectives from Deloitte Insights
    ✓ Link copied to clipboard
    • Contact us
    • Careers at Deloitte
    • Submit RFP
    Follow Deloitte Insights:
    Global office directory Office locations
    UK-EN Location: United Kingdom-English  
    About Deloitte
    • Home
    • Press releases
    • Newsroom
    • Deloitte Insights
    • Global Office Directory
    • Office locator
    • Contact us
    • Submit RFP
    Services
    • Audit & Assurance
    • Consulting
    • Financial Advisory
    • Legal
    • Deloitte Private
    • Risk Advisory
    • Tax
    Industries
    • Consumer
    • Energy, Resources & Industrials
    • Financial Services
    • Government & Public Services
    • Life Sciences & Health Care
    • Technology, Media & Telecommunications
    Careers
    • Careers Home
    • About Deloitte
    • About Deloitte UK
    • Accessibility statement
    • Cookies
    • Health and Safety
    • Modern Slavery Act Statement
    • Privacy statement
    • Regulators & Provision of Services Regulations
    • Deloitte LLP Subprocessors
    • Supplier Standard Terms & Conditions
    • Terms of Use

    © 2023. See Terms of Use for more information.

     

    Deloitte LLP is the United Kingdom affiliate of Deloitte NSE LLP, a member firm of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”). DTTL and each of its member firms are legally separate and independent entities. DTTL and Deloitte NSE LLP do not provide services to clients. Please see About Deloitte to learn more about our global network of member firms.

     

    Deloitte LLP is a limited liability partnership registered in England and Wales with registered number OC303675 and its registered office at 1 New Street Square, London EC4A 3HQ, United Kingdom. A list of members of Deloitte LLP is available at Companies House.